Bill Gates Funded Bioweapons Experiments to Spread Bird Flu to Humans

209
Bill Gates Funded Bioweapons Experiments to Spread Bird Flu to Humans

Microsoft co-founder Bill Gates invested millions of dollars in bioweapons experiments that sought to manipulate bird flu into jumping to mammals and spreading among humans.

The Gates Foundation gave $9.5 million to the University of Wisconsin-Madison and principal investigator Yoshihiro Kawaoka.

The funding paid for experiments to modify Avian Influenza H5N1 viruses to preferentially recognize human-type receptors and rapidly transmit in mammals.

Gates’s role in the experiments was highlighted by world-renowned cardiologist Dr. Peter McCullough.

In a post on X, McCullough stated:

“The Gates Foundation money was also used in a project headed by both Yoshihiro Kawaoka and Ron Fouchier (he previously modified H5N1 to become airborne transmissible in ferrets at the Erasmus Medical Center), where they provided the two additional mutations that would be needed in Egyptian H5N1 viruses to create variants with the mammalian ‘transmissibility features’ identified in the Kawaoka study.

“This indicates that the Gates Foundation funded bioterrorist-like activities involving H5N1, providing blueprints for other bad actors who may want to create a bioweapon.”

Back in 2006, Kawaoka and colleague Taisuke Horimoto published a study aimed at developing new “vaccines” for H5N1 influenza A viruses.

At the time, there was a contrived H5N1 scare that went nowhere compared to what happened with Covid.

Both poultry and people reportedly contracted H5N1 which “raised concerns.”

Kawaoka and Horimoto warned in their 2006 study “that a new influenza pandemic might occur in the near future.”

“Effective vaccines against H5N1 virus are, therefore, urgently needed,” they added.

An H5N1 pandemic never materialized, of course, so now they are trying it all again.

Millions of allegedly infected birds all across America and beyond have been slaughtered.

Meanwhile, the Gates Foundation is funneling masses of cash into more research on H5N1 that conveniently aims to make it more transmissible to humans.

According to UW-Madison, the five-year grant from Gates is all about identifying certain virus “mutations.”

The school says Gates wants to know how those mutations “would serve as early warnings of potential pandemic influenza viruses.”

“Early intervention is critical to the control of influenza virus outbreaks,” Kawaoka commented.

“But in order to intervene, we rely on early recognition of the pandemic potential of newly emerging influenza viruses.”

However, the research states that avian viruses in general do not infect human or other mammalian hosts.

Nevertheless, if the bioweapons experiments can trigger “a mutation,” a new pandemic will be launched, the researchers note.

Kawaoka and Horimoto are reportedly being paid by Gates to identify how a “mutation occurs” in such viruses.

The Gates Foundation claims the experiments are being conducted so that globalists can develop an early warning system to prepare a global outbreak and pandemic.

“The improved ability to predict whether a virus has pandemic potential would be an invaluable asset to the global community,” Kawaoka added in a statement about the research.

“Millions of lives might be saved if intervention methods – such as social distancing, antiviral compound distribution, and vaccine development/production – could be implemented early.”

Details of Gates’s role in funding these experiments come amid growing skepticism about the chance of such viruses occurring naturally.

Experts are warning that viruses only jump between species when they’ve been modified in a lab to do so.

During a Senate hearing on the Covid pandemic this week, expert witnesses Steven C. Quay, M.D., Ph.D., the CEO of Atossa Therapeutics Inc. and a former faculty member at Stanford University’s School of Medicine, asserted that all evidence points to COVID -19 coming from a biolab.

Quay testified that there’s a “one in a billion chance” that COVID-19 emerged in nature rather than from a biolab.

“The statistical probability of finding each feature in nature can be determined and the combined probability that SARS2 came from nature is less than one in a billion,” Quay said.